IgG4-related prostatitis: expanding the spectrum of IgG4-related disease. A systematic review
IgG4-related prostatitis is a rare and likely under-recognised manifestation of IgG4-RD. Its overlap with benign and malignant prostatic disorders delays diagnosis. Serum IgG4 and PSA are unreliable markers of disease and monitoring. Glucocorticoids remain first-line therapy, with surgery in obstructive cases. Multicentre studies are needed to define prevalence, natural history, and optimal management.
Authors
- Cristina Pamfil (ORCID: https://orcid.org/0000-0003-0175-2645)
- R. Talarico
- Georgiana Cabău (ORCID: https://orcid.org/0000-0001-8914-2352)
- Teodor Nicolae Onea
- Camelia Bucsa
- Maia Ioana Mihon
- Ioana Felea
- Victor Surdu
- Laura Damian
Institutions
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
- Azienda Ospedaliera Universitaria Pisana (IT)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2025-10-16
- DOI
- https://doi.org/10.55563/clinexprheumatol/i8eh4g
- Primary Topic
- IgG4-Related and Inflammatory Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00